Monitoring inflammation in psychiatry: Caveats and advice

Eur Neuropsychopharmacol. 2022 Jan:54:126-135. doi: 10.1016/j.euroneuro.2021.09.003. Epub 2021 Oct 2.

Abstract

Most researchers working in the field of immunopsychiatry would agree with the statement that "severe psychiatric disorders are associated with inflammation and more broadly with changes in immune variables". However, as many other fields in biology and medicine, immunopsychiatry suffers from a replication crisis characterized by lack of reproducibility. In this paper, we will comment on four types of immune variables which have been studied in psychiatric disorders: Acute Phase Proteins (AAPs), cytokines, lipid mediators of inflammation and immune cell parameters, and discuss the rationale for looking at them in blood. We will briefly describe the analytical methods that are currently used to measure the levels of these biomarkers and comment on overlooked analytical and statistical methodological issues that may explain some of the conflicting data reported in the literature. Lastly, we will briefly summarize what cross-sectional, longitudinal and mendelian randomization studies have brought to our understanding of schizophrenia (SZ).

Keywords: Bipolar disorders; Blood Biomarkers; Cytokines; Depression; schizophrenia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cross-Sectional Studies
  • Humans
  • Inflammation
  • Psychiatry*
  • Reproducibility of Results
  • Schizophrenia*